Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze NNI stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NNI investment potential.

What is NNI stock price today?

Get real-time NNI stock price, historical data, and price charts on Financhill. Track NNI performance with our advanced analysis tools.

Is NNI a good investment?

Evaluate NNI investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NNI stock?

To buy NNI stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NNI?

View detailed market capitalization data and company valuation metrics for NNI on our comprehensive analysis page.

What is the P/E ratio of NNI?

Use our fundamental analysis tools to view NNI P/E ratio and compare valuation metrics with industry peers.

What are NNI earnings?

View NNI earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Nelnet, Inc. 10K Form

Buy

NNI
Nelnet, Inc.

Last Price:

$131.63

Seasonality Move:

6.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	NNI/Nelnet, Inc. Quarterly
2023-11-07	10Q	NNI/Nelnet, Inc. Quarterly
2023-08-07	10Q	NNI/Nelnet, Inc. Quarterly
2023-05-08	10Q	NNI/Nelnet, Inc. Quarterly
2022-11-07	10Q	NNI/Nelnet, Inc. Quarterly
2022-08-08	10Q	NNI/Nelnet, Inc. Quarterly

Receive NNI News And Ratings

See the #1 stock for the next 7 days that we like better than NNI

NNI Financial Statistics

Sales & Book Value

Annual Sales:	$2.1B
Cash Flow:	$100.8M
Price / Cash Flow:	10.33
Annual Sales:	$101.50
Price / Book:	1.3

Profitability

EPS (TTM):	11.68770
Net Income (TTM):	$415.1M
Gross Margin:	$1.8B
Return on Equity:	12.25%
Return on Assets:	2.98%

Nelnet, Inc. Earnings Forecast

Key Nelnet, Inc. Financial Ratios

The Gross Profit Margin over the past 26 years for NNI is 85.37%.
The Selling, General & Administrative Expenses for NNI have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 394.82% of Operating Income.
The Net Earning history of NNI is 8.12% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 15 years.

Nelnet, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Consumer Finance
Sector:	Financials
Current Symbol:	NNI
CUSIP:	64031N
Website:	nelnetinc.com

Debt

Debt-to-Equity Ratio:	2.14
Current Ratio:	3.19
Quick Ratio:	1.66

Price-to-Earnings

Trailing P/E Ratio:	26.74
Forward P/E Ratio:	15.18

NNI Technical Analysis vs Fundamental Analysis

Buy

Nelnet, Inc. (NNI) is a Buy

Is Nelnet, Inc. a Buy or a Sell?

Nelnet, Inc. stock is rated a Buy

The current Nelnet, Inc. [NNI] share price is $131.70. The Score for NNI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.